Position in BCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,274,210
+$1,728,110 QoQ
Shares Held
227,421
+216.1% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#91
of 316 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IEQ CAPITAL, LLC holds $137,938,276 across 20 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
640,304 | $107,916,836 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
26,102 | $14,142,846 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
561,588 | $2,364,285 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
227,421 | $2,274,210 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
29,746 | $1,902,256 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
99,417 | $1,593,654 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
106,098 | $1,537,360 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
41,170 | $1,394,839 |
All Filings in BCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,274,210 | 227,421 | Shares | Other | 2026-08-11 | |
| 2025-09-30 | $546,100 | 71,950 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,114,471 | 124,383 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $920,272 | 122,703 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $221,358 | 29,436 | Shares | Other | 2025-02-03 | |
| No filing history on record for this holder in this stock. | ||||||